Hong Kong · Delayed Price · Currency is HKD SinoMab BioScience Statistics
Total Valuation
HKG:3681 has a market cap or net worth of HKD 1.56 billion. The enterprise value is 1.63 billion.
| Market Cap | 1.56B |
| Enterprise Value | 1.63B |
Important Dates
The last earnings date was Monday, August 31, 2026.
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:3681 has 1.39 billion shares outstanding. The number of shares has increased by 25.65% in one year.
| Current Share Class | 1.39B |
| Shares Outstanding | 1.39B |
| Shares Change (YoY) | +25.65% |
| Shares Change (QoQ) | +0.95% |
| Owned by Insiders (%) | 16.19% |
| Owned by Institutions (%) | 2.56% |
| Float | 893.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.74 |
| P/TBV Ratio | 3.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.74.
| Current Ratio | 1.35 |
| Quick Ratio | 1.17 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.71 |
| Interest Coverage | -27.51 |
Financial Efficiency
Return on equity (ROE) is -60.37% and return on invested capital (ROIC) is -15.71%.
| Return on Equity (ROE) | -60.37% |
| Return on Assets (ROA) | -14.30% |
| Return on Invested Capital (ROIC) | -15.71% |
| Return on Capital Employed (ROCE) | -31.56% |
| Weighted Average Cost of Capital (WACC) | 6.88% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.22M |
| Employee Count | 95 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.60% in the last 52 weeks. The beta is 0.66, so HKG:3681's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -42.60% |
| 50-Day Moving Average | 1.19 |
| 200-Day Moving Average | 1.42 |
| Relative Strength Index (RSI) | 47.10 |
| Average Volume (20 Days) | 653,325 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -185.73M |
| Pretax Income | -210.75M |
| Net Income | -210.75M |
| EBITDA | -171.14M |
| EBIT | -185.73M |
| Earnings Per Share (EPS) | -0.15 |
Balance Sheet
The company has 236.01 million in cash and 308.05 million in debt, with a net cash position of -72.04 million or -0.05 per share.
| Cash & Cash Equivalents | 236.01M |
| Total Debt | 308.05M |
| Net Cash | -72.04M |
| Net Cash Per Share | -0.05 |
| Equity (Book Value) | 417.36M |
| Book Value Per Share | 0.30 |
| Working Capital | 71.66M |
Cash Flow
In the last 12 months, operating cash flow was -84.83 million and capital expenditures -28.89 million, giving a free cash flow of -113.72 million.
| Operating Cash Flow | -84.83M |
| Capital Expenditures | -28.89M |
| Depreciation & Amortization | 14.80M |
| Net Borrowing | -108.46M |
| Free Cash Flow | -113.72M |
| FCF Per Share | -0.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:3681 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -25.65% |
| Shareholder Yield | -25.65% |
| Earnings Yield | -13.51% |
| FCF Yield | -7.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |